IGC Pharma Inc (AMEX:IGC) currently has a daily average trading volume of 227.23K but it saw 20576782 shares traded in last market. With a market cap of 30.70M USD, the company’s current market price of $0.37 came rising about 15.24 while comparing to the previous closing price of $0.32. In past 52 weeks, the stock remained buoying in the range of price level as high as $0.50 and as low as $0.25. In the recent trading on the day, stock has struck highest price mark of $0.317 while lowest mark touched by it was $0.375.
Over the week, IGC’s stock price is moving 20.59% up while it is 19.37% when we observe its performance for the past one month. Year-to-date it is -9.64% down and over the past year, the stock is showing an upside performance of 8.93%.
The company is expected to be releasing its next quarterly report on 2025-Jun-27, for which analysts forecasted an EPS of -0.03 while estimate for next year EPS is -0.1. In next quarter, company is expected to be making quarterly sales of $494k as analysts are expecting the sales for current fiscal year at $1.45M and seeing the company making $1.5M in sales next year. Moreover, analysts are in estimates of $326k for current-quarter revenue.
Currently, IGC Pharma Inc’s total number of outstanding shares is 80.88M with 9.16% of that held by the insiders while 19.89% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -109.99% and return on equity (ROE) at -104.33%. Stock’s beta reads 1.47. Stock has a price to book (P/B) ratio of 4.68 while price to sale or P/S ratio amounts to 24.17. Its return on asset (ROA) is -76.37% on average.
